Insider Stock Trading History of Olson William C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Olson William C since year 2005. The trader's CIK number is 1327414. At the time of this reporting, Olson William C is the VP, Research & Devel of Progenics Pharmaceuticals Inc . (stock ticker symbol PGNX). See this page for all insider trading activities at Progenics Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Olson William C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-10-03 PGNX Progenics Pharmaceuticals Inc Option Ex 2,605 4.62 12,045
2011-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 6,335 5.46 34,589
2011-06-21 PGNX Progenics Pharmaceuticals Inc Sale 2,872 7.10 20,388
2011-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,373 5.05 11,983
2011-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 2,582 4.83 12,465
2010-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 6,915 4.32 29,858
2010-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,541 4.44 11,282
2010-06-22 PGNX Progenics Pharmaceuticals Inc Sale 2,364 5.80 13,723
2010-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,490 4.56 11,344
2010-01-04 PGNX Progenics Pharmaceuticals Inc Option Ex 2,989 3.78 11,307
2009-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,533 4.26 10,788
2009-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 6,461 5.33 34,437
2009-06-23 PGNX Progenics Pharmaceuticals Inc Sale 2,500 4.73 11,815
2009-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,014 5.65 11,379
2009-01-02 PGNX Progenics Pharmaceuticals Inc Option Ex 1,287 9.13 11,750
2008-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 1,484 6.53 9,690
2008-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 1,484 6.53 9,690
2008-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,296 13.64 31,317
2008-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 1,576 6.52 10,275
2008-01-02 PGNX Progenics Pharmaceuticals Inc Option Ex 570 15.33 8,738
2007-12-03 PGNX Progenics Pharmaceuticals Inc Sale 4,000 19.03 76,112
2007-12-03 PGNX Progenics Pharmaceuticals Inc Option Ex 4,000 4.00 16,000
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 466 19.03 8,867
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 466 19.03 8,867
2007-07-02 PGNX Progenics Pharmaceuticals Inc Option Ex 1,546 18.71 28,925
2007-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 362 21.88 7,920
2006-10-02 PGNX Progenics Pharmaceuticals Inc Option Ex 397 19.58 7,773
2006-07-03 PGNX Progenics Pharmaceuticals Inc Option Ex 1,365 20.45 27,915
2006-06-20 PGNX Progenics Pharmaceuticals Inc Sale 1,000 21.62 21,620
2006-05-05 PGNX Progenics Pharmaceuticals Inc Sale 3,893 24.00 93,432
2006-05-04 PGNX Progenics Pharmaceuticals Inc Sale 10,107 24.00 242,568
2006-05-05 PGNX Progenics Pharmaceuticals Inc Option Ex 3,893 4.00 15,572
2006-05-04 PGNX Progenics Pharmaceuticals Inc Option Ex 10,107 4.00 40,428
2006-04-03 PGNX Progenics Pharmaceuticals Inc Option Ex 305 21.77 6,639
2006-03-20 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 4.00 8,000
2006-03-20 PGNX Progenics Pharmaceuticals Inc Sale 2,000 27.46 54,920
2006-02-06 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 4.00 8,000
2006-02-06 PGNX Progenics Pharmaceuticals Inc Sale 2,000 24.45 48,906
2006-02-21 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 4.00 8,000
2006-02-21 PGNX Progenics Pharmaceuticals Inc Sale 2,000 28.01 56,020
2006-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 330 20.86 6,883
2005-06-21 PGNX Progenics Pharmaceuticals Inc Sale 650 20.00 13,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Olson William C (VP, Research & Devel of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.